Discover 1,727 paid clinical trials in Detroit, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,727
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
for
Type 2 Diabetes, Cortisol Excess
Location: Troy MI, Columbus OH, Cincinnati OH, Chicago IL,
Sponsor: Sparrow Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07296484
Phase 2, Recruiting
An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
for
Hypertension (HTN)
Location: Troy MI, Chicago IL, Ft. Washington MD, Berlin NJ,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07543120
Phase 2, Recruiting
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Adding Pirtobrutinib to the Usual Treatment for People With Newly Diagnosed Richter Transformation, The PIRAMID Trial
for
Richter Syndrome,
Location: Livonia MI, Canton MI, Pontiac MI, Ypsilanti MI,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT07220187
Phase 3, Recruiting
New
Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Livonia MI, Canton MI, Pontiac MI, Ypsilanti MI,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT07393555
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
New
Lifewise Preventive Video Education in Primary Care
for
Prevention Harmful Effects, Health Maintenance,
Location: Livonia MI
Sponsor: Trinity Health-Livonia
Sex: All
Age: 18 - 70+
Code: NCT06730737
Recruiting
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
for
Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma,
Location: Livonia MI, Canton MI, Pontiac MI, Ann Arbor MI,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT05890352
Phase 2, Recruiting
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
for
Myelodysplastic Syndrome
Location: Livonia MI, Canton MI, Pontiac MI, Ypsilanti MI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06577441
Phase 2, Recruiting
Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study
for
Malignant Digestive System Neoplasm,
Location: Livonia MI, Pontiac MI, Ann Arbor MI, Chelsea MI,
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 18+
Code: NCT07215624
Recruiting
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Livonia MI, Canton MI, Pontiac MI, Ypsilanti MI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 60+
Code: NCT07437950
Phase 2, Recruiting
Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer
for
Advanced Clear Cell Renal Cell Carcinoma,
Location: Livonia MI, Canton MI, Ypsilanti MI, Brighton MI,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT07383441
Phase 3, Recruiting
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Livonia MI, Canton MI, Pontiac MI, Ypsilanti MI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06672146
Phase 2, Recruiting
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
for
Locally Advanced Urothelial Carcinoma,
Location: Livonia MI, Canton MI, Pontiac MI, Ypsilanti MI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06524544
Phase 3, Recruiting
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
for
Castration-Sensitive Prostate Carcinoma,
Location: Livonia MI, Canton MI, Pontiac MI, Ypsilanti MI,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: Male
Age: 18+
Code: NCT06931340
Phase 3, Recruiting
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)
for
Core Binding Factor Acute Myeloid Leukemia
Location: Livonia MI, Canton MI, Pontiac MI, Ypsilanti MI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT06917911
Phase 2, Recruiting
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
for
Castration-Resistant Prostate Carcinoma,
Location: Livonia MI, Canton MI, Ypsilanti MI, Brighton MI,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06632977
Phase 2, Recruiting
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Livonia MI, Canton MI, Pontiac MI, Ypsilanti MI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT05554393
Phase 2, Recruiting
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Livonia MI, Canton MI, Pontiac MI, Ann Arbor MI,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 0+
Code: NCT06031688
Phase 2, Recruiting
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Livonia MI, Canton MI, Pontiac MI, Ypsilanti MI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06317649
Phase 2, Recruiting
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Livonia MI, Canton MI, Pontiac MI, Ypsilanti MI,